GSK : Q1 2024 results slides - MarketScreener

May 2, 2024 · All expectations, guidance and outlooks regarding future performance and the dividend should be read together with the section "Guidance and outlooks, assumptions and …

CouponFollow Extension

37%
OFF

Q1 2024 Results Conference Call And Webcast For Investors And …

2 weeks from now

Core EPS grew 37% excluding COVID solutions. Turning to the Total results, operating profit decreased 18% to £1.5 billion, primarily reflecting a charge arising from remeasurements of …

gsk.com

£7
OFF

GSK : Q1 2024 Results Infographic - MarketScreener

2 weeks from now

May 2, 2024 · GSK makes a strong start to 2024 with improving Total sales £7.4bn ...

marketscreener.com

£7
OFF

GSK : Q1 2024 Results Transcript - MarketScreener

2 weeks from now

May 2, 2024 · Slide 9 | Strong start to 2024 with growth in all product areas and regions. In Q1, we delivered growth across all our product areas and regions, with £7.4 billion of sales, up …

marketscreener.com

$3910000
OFF

Transcript : LFTD Partners Inc., Q3 2024 Earnings Call, Nov 15, 2024

2 weeks from now

47 minutes ago · LFTD Partners Inc. and Its Wholly Owned Subsidiary Lifted Made Jointly Borrow A Total of $3,910,000 from Surety Bank. Dec. 19. CI. LFTD Partners Inc., Q3 2023 Earnings …

marketscreener.com

$35
OFF

Transcript : Northland Power Inc., Q3 2024 Earnings Call, Nov 14, …

2 weeks from now

23 hours ago · 04:54pm. Northland Power Brief: Kept Outperform Rating and C$35 Target at National Bank Which Noted "Soft Q3 on thermal production, as construction projects progress …

marketscreener.com

FAQs about GSK : Q1 2024 results slides - MarketScreener Coupon?

Will GSK change its reporting framework in Q1 2024?

GSK has made one update to its reporting framework in Q1 2024 which is to change the description of Adjusted results to Core results to align with European peers in the pharmaceutical industry but with no change to the basis or figures. There is no change to Total Results or the definition of Adjusting items. ...

How do I read GSK's Q1 2024 guidance?

All guidance, outlooks and expectations regarding future performance should be read together with the section “Guidance and outlooks, assumptions and cautionary statements” on page 49 of GSK’s Q1 2024 stock-exchange announcement. 2024 guidance growth at CER, unless stated otherwise. ...

How does GSK perform in 2024?

GSK makes a strong start to 2024 with improving Total sales £7.4bn +10%, +13% including and excluding COVID-19 solutions Vaccines £2.3bn +16%, +22% including and excluding COVID-19 solutions Specialty Medicines £2.5bn +17%, +19% including and excluding COVID-19 solutions, with HIV +14% outlook for the year General Medicines £2.6bn +1% ...

Is GSK plc responsible for the information contained in this content?

Disclaimer GSK plc published this content on 01 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 May 2024 09:35:49 UTC . GSK makes a strong start to 2024 with improving Total sales £7.4bn +10%, +13% ... ...

Will GSK plc review the condensed financial information in the results announcement?

We have been engaged by GSK plc (“the Company”) to review the condensed financial information in the Results Announcement of the Company for the three months ended 31 March 2024. ...

Will GSK pay dividends in Q1 2024?

The Board has declared a first interim dividend for Q1 2024 of 15p per share (Q1 2023: 14p per share). Dividends remain an essential component of total shareholder return and GSK recognises the importance of dividends to shareholders. ...